Smith R G, Abrell J W, Lewis B J, Gallo R C
J Biol Chem. 1975 Mar 10;250(5):1702-9.
The preparation and properties of an antiserum to human DNA polymerase I (6 to 8 S) are described. Care was taken in the purification of the antigen to remove certain other DNA polymerases found in human cells. An incubation of antigen and antiserum lasting about 48 hours is necessary to achieve maximal inhibition. About 1 mug of the antipolymerase immunoglobulin G, prepared in rats, neutralizes 60% of the activity present in 54 ng of the enzyme. Tritrations varying both antiserum and enzyme demonstrate clear regions of antigen and antibody excess. Inhibition of enzyme activity is about the same whether the templateprimer is (dA)n-(dT)12-18, or partially digested DNA. An assay was developed which measures the remaining activity in the supernatant after precipitation of enzyme-antibody complexes with goat anti-rat immunoglobulin G. In this assay, 2.2 mug of the antipolymerase immunoglobulin G quantitatively bind 33 ng of DNA polymerase I. With use of the direct neutralization assay and the immuno-precipitation test, we found little, if any, antigenic relationship between DNA polymerase I and DNA polymerase II (3.4 S). Similarly, little, if any, relationship was found to the DNA polymerases from five RNA tumor viruses. The activities of RNA-directed DNA polymerases from the blood leukocytes of two patients with acute myelogenous leukemia and from the placentas of rhesus monkeys were not inhibited in neutralization assays which were shortened because these enzymes were thermolabile. In identically shortened neutralization assays, the antipolymerase immunoglobulin G neutralized up to 76% of the activity of DNA polymerase I. In addition to its utility in distinguishing cellular DNA polymerases, the rat antiserum should be useful reagent for testing of novel DNA polymerases isolated in small quantities from human tumors for contamination with DNA polymerase I. This enzyme is present in abundance in proliferating tissue and often confuses the biochemical characterization of these novel enzymes.
本文描述了人DNA聚合酶I(6至8S)抗血清的制备及其特性。在纯化抗原时十分小心,以去除人细胞中发现的某些其他DNA聚合酶。抗原与抗血清孵育约48小时对于实现最大抑制是必要的。在大鼠中制备的约1微克抗聚合酶免疫球蛋白G可中和54纳克该酶中60%的活性。对抗血清和酶进行不同的滴定显示出抗原和抗体过量的清晰区域。无论模板引物是(dA)n - (dT)12 - 18还是部分消化的DNA,酶活性的抑制情况大致相同。开发了一种检测方法,在使用山羊抗大鼠免疫球蛋白G沉淀酶 - 抗体复合物后,测量上清液中的剩余活性。在该检测中,2.2微克抗聚合酶免疫球蛋白G可定量结合33纳克DNA聚合酶I。使用直接中和检测和免疫沉淀试验,我们发现DNA聚合酶I与DNA聚合酶II(3.4S)之间几乎没有抗原关系。同样,与五种RNA肿瘤病毒的DNA聚合酶之间也几乎没有关系。两名急性髓性白血病患者血液白细胞和恒河猴胎盘的RNA指导的DNA聚合酶活性在中和试验中未被抑制,因为这些酶不耐热,所以中和试验被缩短。在同样缩短的中和试验中,抗聚合酶免疫球蛋白G可中和高达76%的DNA聚合酶I活性。除了在区分细胞DNA聚合酶方面的用途外,大鼠抗血清对于检测从人肿瘤中少量分离的新型DNA聚合酶是否被DNA聚合酶I污染应是一种有用的试剂。这种酶在增殖组织中大量存在,常常使这些新型酶的生化特性分析变得复杂。